LIFEMD, INC. Proceeds from Common Stock Issued
LIFEMD, INC. (LFMD) reported Proceeds from Common Stock Issued of $8.72 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-03-10
- LIFEMD, INC. proceeds from issuance of common stock for the quarter ending 2025-12-31 was $0.00.
- LIFEMD, INC. proceeds from issuance of common stock for the quarter ending 2025-09-30 was $8.70M.
- LIFEMD, INC. proceeds from issuance of common stock for the quarter ending 2021-12-31 was $0.00.
- LIFEMD, INC. proceeds from issuance of common stock for the quarter ending 2020-12-31 was $0.00.
- LIFEMD, INC. proceeds from issuance of common stock for fiscal 2025 was $8.72M.
- LIFEMD, INC. proceeds from issuance of common stock for fiscal 2023 was $10.00M.
- LIFEMD, INC. proceeds from issuance of common stock for fiscal 2021 was $493.48K, a 78.90% decline from fiscal 2020.
- LIFEMD, INC. proceeds from issuance of common stock for fiscal 2020 was $2.34M, a 568.10% increase from fiscal 2019.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $8.70M derived: sum of 2 quarters · filed 2026-03-10 | $8.72M 10-K · filed 2026-03-10 | |||
| 2025-09-30 | $8.70M 10-Q · filed 2025-11-17 | $8.72M 10-Q · filed 2025-11-17 | ||||
| 2023-12-31 | $10.00M 10-K · filed 2025-03-11 | |||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $493.48K 10-K · filed 2023-03-22 | ||||
| 2021-09-30 | $493.48K 10-Q · filed 2022-11-10 | |||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | $2.09M derived: sum of 2 quarters · filed 2022-03-07 | $2.34M 10-K · filed 2022-03-07 | |||
| 2020-09-30 | $2.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $2.34M 10-Q · filed 2021-11-10 | ||||
| 2020-06-30 | $250.00K 10-Q · filed 2021-08-13 | |||||
| 2019-12-31 | $350.00K 10-K · filed 2020-03-30 | |||||
| 2017-12-31 | $749.89K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $1.43M derived: sum of 2 quarters · filed 2019-04-01 | $1.43M derived: sum of 3 quarters · filed 2019-04-01 | $673.25K 10-K · filed 2019-04-01 | -$76.65K 10-K · filed 2018-04-02 | |
| 2017-09-30 | $676.40K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2018-12-04 | $676.40K derived: sum of 2 quarters · filed 2018-12-04 | $673.25K 10-Q/A · filed 2018-12-04 | -$76.65K 10-Q · filed 2018-11-14 | $590.91K derived: sum of 4 quarters · filed 2018-12-04 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$3.15K 10-Q · filed 2018-08-17 | -$85.48K derived: sum of 3 quarters · filed 2018-06-27 | |||
| 2017-03-31 | -$3.15K 10-Q · filed 2018-06-27 | -$85.48K derived: sum of 2 quarters · filed 2018-06-27 | ||||
| 2016-12-31 | -$82.33K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -$87.05K 10-K · filed 2018-04-02 | ||||
| 2016-09-30 | -$4.72K 10-Q · filed 2017-11-14 | |||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-05-24 | $0.00 derived: sum of 2 quarters · filed 2017-11-13 | -$10.80K 10-K · filed 2017-05-24 | |||
| 2015-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2017-11-13 | -$10.80K 10-Q/A · filed 2017-11-13 | ||||
| 2015-06-30 | -$10.80K 10-Q · filed 2016-08-15 | |||||
| 2013-12-31 | $175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $175.00K derived: sum of 2 quarters · filed 2015-03-30 | $175.00K 10-K · filed 2015-03-30 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 10-Q · filed 2013-11-14 | ||||
| 2013-06-30 | $0.00 10-Q · filed 2013-08-14 | |||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $2.59K derived: sum of 2 quarters · filed 2014-03-28 | $345.88K 10-K · filed 2014-03-28 | |||
| 2012-09-30 | $2.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $345.88K 10-Q · filed 2013-11-14 | ||||
| 2012-06-30 | $343.30K 10-Q · filed 2013-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |